Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q1 EPS by 44c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $67.50 -6.07%
Financial Fact:
General and administrative expenses: 2.28M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
General and administrative expenses: 2.28M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of ($1.24), $0.44 worse than the analyst estimate of ($0.80). Revenue for the quarter came in at $3.55 million versus the consensus estimate of $37.66 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Worthington Industries (WOR) Tops Q1 EPS by 7c
- KeyBanc Sees 'A Potential Catalyst for Earnings Growth and Value Creation' for Acadia Realty Trust (AKR)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
